Home » Call for Papers and Opinion Pieces!
Call for Papers and Opinion Pieces!
Is there a technical challenge that you've overcome, or a nonproprietary best practice that you would like to share with your peers? Perhaps you have a strong opinion about something you’ve encountered in your professional life or commentary covering a serious issue facing the industry?
Your expertise, professional insight and opinion are extremely valuable to us. Interested? Simply submit a brief summary of what you might like to write for us (from a sentence or two for an opinion piece brief, to a 200-300-word abstract for a technical piece) to the editor in chief, Steve Kuehn (email@example.com). From there, the Pharmaceutical Manufacturing editorial team will evaluate, discuss, and consider it for publication.
Technical articles should be up to 2,500 words long, technically detailed but written in active, conversational (rather than academic journal) style. Opinion pieces should be about 800 words, and blog posts no more than 400 words.
Below is a link to our 2013 editorial calendar, to give you an idea of what we plan to cover this year.
Let your voice be heard! We look forward to hearing from you.
Merck Stops Development of Parkinsonís DrugFrom Bloomberg
Merck & Co. will end development of preladenant because a preliminary review of late-stage clinical trials suggests it doesnít work
French Drugmaker on Trial for Suspected DeathsFrom Yahoo! News
Servier Laboratories, French drugmaker responsible for producing diabetes and weight loss drug Mediator, faces charges for deception in relation to the suspected deaths of hundreds of people.
Novo Acquires Xellia Pharmaceuticals for $700 MillionFrom PharmaTimes Online
Novo A/S has acquired Xellia Pharmaceuticals of Norway
Royalty Increases Bid as Elan Unveils AcquisitionsFrom PharmaTimes Online
Royalty Pharma has resurfaced to raise its bid to acquire the Irish drugmaker Elan
New Asthma Drug Offers Hope for PatientsFrom Forbes
An experimental asthma drug could give new hope to patients for whom existing medicines are not enough
Syrian Pharma Production Nearly Halted by WarFrom AFP
A shortage of foreign currency has brought production to a near halt in Syria
Camfil APC Opens Manufacturing Plant in the UKFrom Camfil
Camfil announced the grand opening of its new 40,000-sq.-ft. facility
Actavis Acquiring Warner Chilcott for $8.5BFrom AP
Actavis to buy Warner Chilcott in an all-stock transaction
Northwest Analytics Launches Next Generation Enterprise Manufacturing Intelligence SolutionFrom Northwest Analytics
NWA Focus EMI Delivers Real Time Process Intelligence and Unique Accelerating Modules - a Shared Knowledge Base and Manufacturing-Centric Collaboration
Innovative Clinical Development Partnership Announced By Quintiles and Merck SeronoFrom MarketWatch.com
Agreement creates unique strategic collaboration for development and clinical trial execution
- All news »
- Popular Articles
- Newest Articles
- Popular Downloads
- Featured White Papers